Lymph node metastasis, chemotherapy, and EGFR status significantly differed depending on ALKBH5 expression, whereas tumor status, lymph node metastasis, pathological stage, chemotherapy, and EGFR status significantly differed depending on FTO expression. This evidence concerns the gene FTO and metastatic malignant neoplasm in the lymph nodes.